BRIUMVI is a prescription medication used to treat adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. It is not known if BRIUMVI is safe or effective in children

​

BRIUMVI is the only B-cell therapy for people with RMS administered as a 1-HOUR INFUSION, TWICE PER YEAR following the starting dose​​